First physician in Memphis to use FDA approved stent

Today, Dr. Jon Roberts at Germantown Methodist Hospital used a new stent system developed and approved exclusively for treating patients with venous disease.

Recently approved by the U.S. Food and Drug Administration, the VICI Venous Stent System™ provides both clinicians and patients with an alternative treatment option that will provide patients with an increased quality of life.

Venous disease currently affects nearly 40 percent of the population in the U.S. and it can be caused by conditions such as deep vein thrombosis, Post Thrombotic Syndrome (PTS) and compression diseases such as May-Thurner syndrome. If left untreated, venous disease can cause pain, swelling and the formation of ulcers that can permanently affect a patient’s quality of life.

300,000 to 600,000 Americans suffering from venous disease. It currently affects nearly 40 percent of the population in the U.S. and it can be caused by conditions such as deep vein thrombosis, Post Thrombotic Syndrome (PTS) and compressive diseases such as May-Thurner syndrome. If left untreated, venous disease can cause pain, swelling and the formation of ulcers that can permanently affect a patient’s quality of life.

Endovascular treatment for venous disease needs to account for the anatomical presentation of the venous system, which relies on valves and muscle contractions to bring blood back to the heart. The iliofemoral veins are located deep in the abdomen and are subject to directional forces and torsion or twisting. To help solve for this, the VICI Venous Stent System was specifically designed to be flexible and crush resistant, thus restoring blood blow from the lower limbs.